MAAT-LOGOApril 5, 2016: Maat Pharma & Accinov sign a partnership agreement to manufacture investigational new drugs

MaaT Pharma and Accinov have announced the signing of a partnership agreement for the creation of a GMP platform for the production of clinical batches for an investigational new drug to cure dysbiosis (imbalance of exchanges between the intestinal microbiome and the host) through  autologous micro-biotherapy, a solution which is currently totally unique

MaaT-Pharma&Accinov Press-Release

logo-accinov-baseline